Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 265 | 0 | 0 | 0 | 0 |
| Cost of Goods | 154 | N/A | N/A | N/A | N/A |
| Gross Profit | 112 | N/A | N/A | N/A | N/A |
| Operating Expenses | 4,424 | 2,893 | 3,306 | 3,134 | 1,934 |
| Operating Income | -4,312 | -2,893 | -3,306 | -3,134 | -1,934 |
| Interest Expense | 0 | N/A | 0 | 0 | 360 |
| Other Income | 29 | -79 | 48 | 32 | 51 |
| Pre-tax Income | -4,283 | -2,972 | -3,259 | -3,101 | -2,244 |
| Net Income Continuous | -4,283 | -2,972 | -3,259 | -3,101 | -2,244 |
| Net Income | $-4,283 | $-2,972 | $-3,259 | $-3,101 | $-2,244 |
| EPS Basic Total Ops | N/A | N/A | N/A | N/A | -0.37 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | N/A | -0.37 |
| EPS Diluted Total Ops | N/A | N/A | N/A | N/A | -0.37 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | N/A | -0.37 |
| EBITDA(a) | $-4,107 | $-2,864 | $-3,230 | $-3,074 | $-1,847 |